108 related articles for article (PubMed ID: 20860154)
1. [The PLATO study].
Caracciolo M; Ardissino D; De Servi S; D'Urbano M
G Ital Cardiol (Rome); 2010 May; 11(5):351-6. PubMed ID: 20860154
[No Abstract] [Full Text] [Related]
2. Overview of the 2010 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee meeting regarding ticagrelor.
Gaglia MA; Waksman R
Circulation; 2011 Feb; 123(4):451-6. PubMed ID: 21242480
[No Abstract] [Full Text] [Related]
3. [Ticagrelor versus clopidogrel in patients with acute coronary syndromes: results of the PLATO study].
Preobrazhenskiĭ DV
Kardiologiia; 2010; 50(1):68. PubMed ID: 20144161
[No Abstract] [Full Text] [Related]
4. Effect size of ticagrelor over clopidogrel in the Platelet Inhibition and Patient Outcomes (PLATO) trial: from statistics to clinical judgment.
Capodanno D; Calvi V; Tamburino C
J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):162-3. PubMed ID: 22237463
[No Abstract] [Full Text] [Related]
5. Advances in antiplatelet treatment for acute coronary syndromes.
Eshaghian S; Shah PK; Kaul S
Heart; 2010 May; 96(9):656-61. PubMed ID: 19910292
[TBL] [Abstract][Full Text] [Related]
6. Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial.
James S; Budaj A; Aylward P; Buck KK; Cannon CP; Cornel JH; Harrington RA; Horrow J; Katus H; Keltai M; Lewis BS; Parikh K; Storey RF; Szummer K; Wojdyla D; Wallentin L
Circulation; 2010 Sep; 122(11):1056-67. PubMed ID: 20805430
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy.
Storey RF; Angiolillo DJ; Patil SB; Desai B; Ecob R; Husted S; Emanuelsson H; Cannon CP; Becker RC; Wallentin L
J Am Coll Cardiol; 2010 Oct; 56(18):1456-62. PubMed ID: 20832963
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of ticagrelor: a reversible P2Y12 receptor antagonist.
Anderson SD; Shah NK; Yim J; Epstein BJ
Ann Pharmacother; 2010 Mar; 44(3):524-37. PubMed ID: 20124464
[TBL] [Abstract][Full Text] [Related]
9. The PLATO trial: do you believe in magic?
Serebruany VL; Atar D
Eur Heart J; 2010 Apr; 31(7):764-7. PubMed ID: 20007979
[TBL] [Abstract][Full Text] [Related]
10. Clopidogrel and [symbol: see text] ticlopidine--improvements on aspirin?
Drug Ther Bull; 1999 Aug; 37(8):59-61. PubMed ID: 10696686
[TBL] [Abstract][Full Text] [Related]
11. Current Antiplatelet Agents in Acute Coronary Syndrome.
Sachdeva A
J Assoc Physicians India; 2015 Jan; 63(1):75-6. PubMed ID: 26591137
[No Abstract] [Full Text] [Related]
12. [New thrombocyte inhibitor. Fewer ischemic complications in acute coronary syndrome].
MMW Fortschr Med; 2009 Sep; 151(36):50. PubMed ID: 19813542
[No Abstract] [Full Text] [Related]
13. Prasugrel: Clinical development and therapeutic application.
Guerra DR; Tcheng JE
Adv Ther; 2009 Nov; 26(11):999-1011. PubMed ID: 20020231
[TBL] [Abstract][Full Text] [Related]
14. Aspirin combined with clopidogrel (Plavix) decreases cardiovascular events in patients with acute coronary syndrome.
Walker CW; Dawley CA; Fletcher SF
Am Fam Physician; 2007 Dec; 76(11):1643-5. PubMed ID: 18092705
[No Abstract] [Full Text] [Related]
15. Treating Acute Coronary Syndrome.
Khan N
Consult Pharm; 2015 Sep; 30(9):486. PubMed ID: 27405115
[No Abstract] [Full Text] [Related]
16. Non-interventional management of acute coronary syndromes.
Timmis A
BMJ; 2011 Jun; 342():d3263. PubMed ID: 21685435
[No Abstract] [Full Text] [Related]
17. The TRITON versus PLATO trials: differences beyond platelet inhibition.
Serebruany VL
Thromb Haemost; 2010 Feb; 103(2):259-61. PubMed ID: 20024505
[TBL] [Abstract][Full Text] [Related]
18. [Letter to Kardiologia Polska concerning optimal treatment of myocardial infarction].
Grajek S
Kardiol Pol; 2012; 70(2):213-4. PubMed ID: 22427099
[No Abstract] [Full Text] [Related]
19. Aspirin, ticlopidine and clopidogrel in and out of the catheterization laboratory.
Berger PB
J Invasive Cardiol; 1999 Jun; 11 Suppl A():20A-29A. PubMed ID: 10745607
[No Abstract] [Full Text] [Related]
20. [Secondary stroke prevention according to the PRoFESS Study. What are the sequelae for practical therapy?].
Diener C
MMW Fortschr Med; 2008 May; 150(21):7. PubMed ID: 18578065
[No Abstract] [Full Text] [Related]
[Next] [New Search]
